Globus Medical Inc - Class A (GMED) Company Profile & Statistics

Globus Medical Inc - Class A
GMED
(NYSE)
N/A
51.95
+1.47 (+2.91%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
51.19
High
51.95
Low
50.90

About Globus Medical Inc - Class A

CEO

Daniel T. Scavilla

Headquarters

2560 general armistead avenue

audubon, pa 19403, united states

Auditor

Deloitte & Touche LLP

Employees

5,000

Share Holders

Website

www.globusmedical.com

Industry

medical specialties

Sector

health technology

Company Overview

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.

Globus Medical Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	7.03B
Enterprise Value	6.98B
Enterprise Value/EBITDA (ttm)	19.48
Price to Earnings Ratio (ttm)	22.30
Price to Book (mrq)	1.77
Price to Sales (ttm)	4.48
Price to Cash (ytd)	14.40

Profitability

Gross Margin (ttm)	67.46%
Operating Margin (ttm)	16.99%
Profit Margin (ttm)	10.06%
Return on Equity (ttm)	8.82%
Return on Invested Capital (ttm)	5.84%
Return on Assets (ttm)	7.20%

Income Statement

Revenue (ttm)	1.57B
Revenue Per Share (ttm)	11.59
Gross Profit (ttm)	1.02B
EBITDA (ttm)³	358.50M
Net Income Avi to Common (ttm)	122.87M
Diluted EPS (ttm)	1.17

Share Statistics

Beta (5Y Monthly)	1.11
52-Week Change	-11.12%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	135.37M
Dividend Yield	0.00%
Float ⁴	102.48M
% Held by Insiders	24.30%
% Held by Institutions	95.16%

Balance Sheet

Total Cash (mrq)	517.79M
Total Cash Per Share (mrq)	3.82
Total Debt (mrq)	417.40M
Total Debt/Equity (mrq)	10.44%
Current Ratio (mrq)	4.88%
Quick Ratio (mrq)	2.72%
Book Value Per Share (mrq)	29.32

Cash Flow

Operating Cash Flow Per Share (ytd)	2.12
Free Cash Flow (ytd)	165.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Globus Medical Inc - Class A

Trade With A Regulated Broker